Serum MFAP4, a novel potential biomarker for liver cirrhosis screening, correlates with transient elastography in NAFLD patients.
JGH Open
; 7(3): 197-203, 2023 Mar.
Article
in En
| MEDLINE
| ID: mdl-36968563
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Language:
En
Journal:
JGH Open
Year:
2023
Document type:
Article